[Editorial comment. Neuromuscular diseases]

Orv Hetil. 2011 Sep 25;152(39):1551. doi: 10.1556/OH.2011.29183.
[Article in Hungarian]
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Algorithms
  • Autoimmunity
  • Decision Making
  • Dermatomyositis / diagnosis
  • Dermatomyositis / therapy
  • Epigenesis, Genetic
  • Genetic Predisposition to Disease
  • Glycogen Storage Disease Type II / diagnosis
  • Glycogen Storage Disease Type II / drug therapy
  • Glycogen Storage Disease Type II / enzymology
  • Humans
  • Muscular Dystrophy, Facioscapulohumeral / diagnosis
  • Muscular Dystrophy, Facioscapulohumeral / genetics
  • Myasthenia Gravis / immunology
  • Neuromuscular Agents / therapeutic use*
  • Neuromuscular Diseases / diagnosis
  • Neuromuscular Diseases / drug therapy
  • Neuromuscular Diseases / genetics*
  • Neuromuscular Diseases / immunology*
  • Polymyositis / diagnosis
  • Polymyositis / therapy
  • Polyneuropathies / immunology

Substances

  • Neuromuscular Agents